Brief: Herantis Pharma And Nanoform Enter Collaboration Agreement

Nanoform Finland Oyj

09/02/2021 06:43

Feb 9 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA AND NANOFORM ENTER INTO AGREEMENT FOR
PROOF OF
CONCEPT COLLABORATION
    * COLLABORATION PROVIDES FOR FORMULATION POCS TO COMBINE
HERANTIS'
CDNF THERAPY FOR PARKINSON'S DISEASE, WITH NANOFORM NANOPARTICLE
TECHNOLOGY

Source text for Eikon:  ID:nWkr47QZ7s 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))